Lv11
10 积分 2023-07-30 加入
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
2小时前
已完结
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
4个月前
已完结
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
4个月前
已完结
肝癌微环境重塑与免疫治疗策略
5个月前
已完结
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
5个月前
已完结
Robotic liver resection of caudate lobe with 3-D rendering and intraoperative ICG-fluorescence for giant hemangioma
6个月前
已完结
皖公网安备34019202002308
